News

PreveCeutical’s Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer

Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

1 year ago

Medexus and pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for Trecondyv (treosulfan for injection) in Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 18, 2024) - Earlier in November 2024, Medexus Pharmaceuticals (TSX: MDP) (OTCQX:…

1 year ago

New Report on Tackling Plastic Waste Highlights SC Johnson for Achieving Key Packaging Goals Early

SC Johnson Leads Industry in Reuse Models in the Ellen MacArthur Foundation's latest Global Commitment Progress ReportRacine, Wisconsin--(Newsfile Corp. -…

1 year ago

Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies

Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment…

1 year ago

Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse

Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty…

1 year ago

Buyback of Class B shares in Essity during week 46, 2024

STOCKHOLM, Nov. 18, 2024 /PRNewswire/ -- Between November 11, 2024, and November 15, 2024, Essity Aktiebolag (publ) repurchased a total…

1 year ago

New Report from Clarivate and Healthcare Executive Explores Mainland China’s Biopharma Revolution and Increasing Global Influence

New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON, Nov. 18,…

1 year ago

Zero Candida Applies to List its Shares on the TSX Venture Exchange

VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ -- Zero Candida Technologies Inc. (the "Company" or "Zero Candida") (TSXV: ZCT), a technology…

1 year ago

UK Regulator MHRA Grants Nanomerics Clinical Trials Authorisation Notice for its Upcoming OC134 Clinical Trial

LONDON, UNITED KINGDOM / ACCESSWIRE / November 18, 2024 / Nanomerics Ltd., a private speciality pharmaceutical company announced that it…

1 year ago

Hometown NP Expands Telepsychiatry Services to 39 States Nationwide

FRANKFORT, IL / ACCESSWIRE / November 17, 2024 / Hometown NP, co-founded by Dr. Chime Ajiere, DNP, in 2023, is…

1 year ago